The European Medicines Agency (EMA) updates its engagement framework with patients, consumers and their organisations

The European Medicines Agency (EMA) engagement framework aims to

  • Facilitate participation of patients and consumers in regulatory activities all along the entire lifecycle of medicines;
  • Foster the development of guidance and methodologies to increase collection and use of relevant patient experience data in the context of regulatory decision making;
  • Ensure that patients, consumers and their representative organisations are consulted and, where appropriate, involved in the development of EMA policies and plans
  • Support optimal participation of patients and consumers in EMA activities by establishing a training programme.

Download the document at this link


Scroll to Top